Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: No major role for class II or class III regions of HLA

Genes and Immunity

Volumn 3, Issue 6, 2002, Pages 350-358

  Peacock, C S ^a   Sanjeevi, C B ^b   Shaw, M A ^c   Collins, A ^d   Campbell, R D ^e   March, R ^f   Silveira, F ^g   Costa, J ^h   Coste, C H ⁱ   Nascimento, M D ^h   Siddiqui, R ^j   Shaw, J J ^g   Blackwell, Jennie M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e MRC HGMP Resource Centre   (United Kingdom)

^f ASTRAZENECA   (United Kingdom)

^g INSTITUTO EVANDRO CHAGAS   (Brazil)

^h Universidade Federal do Maranho   (Brazil)

ⁱ Universidade de Piaui   (Brazil)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

Genetic susceptibility; HLA; Multicase families; Visceral leishmaniasis

Indexed keywords

ANTIMONY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BRAZIL; DATA ANALYSIS; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC REGULATION; GENOTYPE; HAPLOTYPE; HUMAN; NONPARAMETRIC TEST; PARAMETRIC TEST; PENETRANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SEGREGATION ANALYSIS; SIBLING; STATISTICAL ANALYSIS; VISCERAL LEISHMANIASIS; ANIMAL; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LEISHMANIA DONOVANI;

ANIMALS; BRAZIL; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LOD SCORE;

EID: 0037798558     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363852     Document Type: Article

References (57)

1. Ho M, Siongok TK, Lyerly WH, Smith DH. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 1982; 76: 741-746.
2. Sacks DL, Lal SL, Shrivastava SN, Blackwell JM, Neva FA. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol 1987; 138: 908-913.
3. Davies CR, Llanos-Cuentas EA, Pyke SD, Dye C. Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity. Epidemiol Infect 1995; 114: 297-318.
4. Cabello PH, Lima AM, Azevedo ES, Kriger H. Familial aggregation of Leishmania chagasi infection in northeastern Brazil. Am J Trop Med Hyg 1995; 52: 364-365.
5. Peacock CS, Collins A, Shaw MA et al. Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 2001; 20: 383-396.
6. Blackwell J, Freeman J, Bradley D. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 1980; 283: 72-74.
7. Blackwell JM. Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics 1983; 18: 101-109.
8. Blackwell JM, Roberts MB. Immunomodulation of murine visceral leishmaniasis by administration of monoclonal anti-Ia antibodies: differential effects of anti-I-A vs anti-I-E antibodies. Eur J Immunol 1987; 17: 1669-1672.
9. Kaye PM, Cooke A, Lund T, Wattie M, Blackwell JM. Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. Eur J Immunol 1992; 22: 357-364.
10. Barral-Netto M, Badaro R, Barral A et al. Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 1991; 163: 853-857.
11. McGuire W, Hill ASV, Allsop CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
12. Khoo SH, Pepper L, Snowden N et al. Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression. AIDS 1997; 11: 423-428.
13. Roy S, McGuire W, Mascie-Taylor CGN et al. TNF promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176: 530-532.
14. Conway DJ, Holland MJ, Bailey RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997; 65: 1003-1006.
15. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179: 287-290.
16. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-880.
17. Shaw MA, Donaldson IJ, Collins A et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun 2001; 2: 196-204.
18. Cabrera M, Shaw M-A, Sharples C et al. Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264.
19. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation. Proc NY Acad Sci USA 1997; 94: 3195-3199.
20. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
21. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
22. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C - >A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449.
23. Singh N, Sundar S, Williams F et al. Molecular typing of HLA class I and class II antigens in Indian kala-azar patients. Trop Med Int Health 1997; 2: 468-471.
24. Faghiri Z, Tabei SZ, Taheri F. Study of the association of HLA class I antigens with kala-azar. Hum Hered 1995; 45: 258-261.
25. Meddeb-Garnaoui A, Gritli S, Garbouj S et al. Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis. Hum Immunol 2001; 62: 509-517.
26. Amendoiera R, Guilherme L, Martin M et al. HLA and visceral leishmaniasis in families of endemic area in northeast Brazil. Mem I Oswaldo Cruz 1988; 83: 119.
27. Blackwell JM, Black GF, Peacock CS et al. Immunogenetics of leishmanial and mycobacterial infections: The Belem Family Study. Phil Trans Roy Soc B 1997; 352: 1331-1345.
28. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40: 1-14.
29. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
30. Kemp M, Kurtzhals JAL, Bendtzen K et al. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993; 61: 1069-1073.
31. Kurtzhals JA, Hey AS, Jardim A et al. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol 1994; 96: 416-21.
32. Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol 1988; 140: 3971-3977.
33. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R (eds). The Leishmaniasis in Biology and Medicine. Academic Press: London, 1987, pp 1-120.
34. Nascimento MD, Costa JM, Fiori BI et al. The epidemiological determinant aspects in the maintenance of visceral leishmaniasis in the state of Naranhao, Brazil. Rev Soc Bras Med Trop 1996; 39: 233-240.
35. Grimaldi G, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 1989; 41: 687-725.
36. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified beta-globin and HLA-DQalpha DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163-166.
37. Bidwell J. Advances in DNA-based HLA-typing methods. Immunol Today 1994; 15: 303-307.
38. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: Tsuji K (ed). HLA: OUP, 1999, pp 397-419.
39. Lundin KE, Ronningnen KS, Aono S et al. HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 1989; 34: 233-241.
40. Ronningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol 1989; 26: 215-225.
41. Hsieh SL, March RE, Khanna A, Cross SJ, Campbell RD. Mapping of 10 novel microsatellites in the MHC class III region: application to the study of autoimmune disease. J Rheumatol 1997; 24: 220-222.
42. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-β) gene. J Immunol 1991; 147: 1053-1059.
43. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-154.
44. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1993; 1: 353.
45. Messer G, Spengler U, Jung MC et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-α production. J Exp Med 1991; 173: 209-219.
46. Morton NE, Shields DC, Collins A. Genetic epidemiology of complex phenotypes. Ann Hum Genet 1991; 55: 301-314.
47. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000; 25: 12-13.
48. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
49. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990; 46: 229-241.
50. Risch N. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 1990; 46: 242-253.
51. Holmans P. Asymptotic properties of affected-sib-pair linkage analysis. Am J Hum Genet 1993; 52: 362-374.
52. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected sib-pair linkage study with single locus and multiple tightly-linked markers. Am J Hum Genet 1995; 37: 1221-1232.
53. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
54. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.
55. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233.
56. Dudbridge F, Koeleman BP, Todd JA, Clayton DG. Unbiased application of the transmission disequilibrium test to multilocus haplotypes. Am J Hum Genet 2000; 66: 2009-2012.
57. Klitz W, Stephens JC, Grote M, Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet 1995; 57: 1436-1444.